Cytopenia among CML Patients on Imatinib in Kenya: Types, Grades, and Time Course.

Angela McLigeyo,Jamilla Rajab,Mohammed Ezzi,Peter Oyiro,Yatich Bett,Andrew Odhiambo,Matilda Ong'ondi, Sitna Mwanzi, Mercy Gatua, NAOthieno- Abinya

Advances in hematology（2020）

引用 2|浏览2

暂无评分

摘要

Monocytopenia, especially anemia, was the most common type of cytopenia. The cytopenia was predominantly grade 2, developed in majority of the patients within 6 months after imatinib initiation, and had resolved by 24-36 months after imatinib initiation.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要